Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study
Xinyi Hong,1,* Shanhu Qiu,2,* Xia Wu,3 Sizhen Chen,4 Xiaoxiang Chen,5 Bei Zhang,6 Aiqin He,3 Yun Xu,7 Jianqing Wang,8 Yingchun Gao,9 Xizhong Xu,10 Li Sun,11 Yang Zhang,12 Libing Xiang,13 Jundong Zhou,14 Qun Guan,15 Yanling Zhu,16 Haiyan Liu,17 Hao Xu,18 Ying Zhou,19 Bingwei Chen,4 Ya...
Saved in:
Main Authors: | Hong X (Author), Qiu S (Author), Wu X (Author), Chen S (Author), Chen X (Author), Zhang B (Author), He A (Author), Xu Y (Author), Wang J (Author), Gao Y (Author), Xu X (Author), Sun L (Author), Zhang Y (Author), Xiang L (Author), Zhou J (Author), Guan Q (Author), Zhu Y (Author), Liu H (Author), Xu H (Author), Zhou Y (Author), Chen B (Author), Shen Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Predictive Model for Endometrial Carcinoma Based on Hysteroscopic Data
by: Wu H, et al.
Published: (2023) -
Treatment of HER2-Positive Breast Cancer with Brain Metastases Using Anlotinib and Trastuzumab Deruxtecan: A Case Report
by: Chen Y, et al.
Published: (2024) -
A novel pH–enzyme-dependent mesalamine colon-specific delivery system
by: Jin L, et al.
Published: (2016) -
Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in the Treatment of Patients with Advanced Primary Hepatocellular Carcinoma: A Retrospective, Real-World Study in China
by: Chen XQ, et al.
Published: (2022) -
NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma
by: Yu X, et al.
Published: (2023)